What is NMN (Nicotinamide Mononucleotide)?
A NAD+ precursor studied for cellular energy and longevity.
NMN is a precursor to NAD+, a coenzyme essential for cellular energy production. Animal studies show promising longevity effects. Human data is emerging but limited. FDA has raised regulatory questions about its status as a supplement.
What the evidence says
The overall evidence grade for NMN (Nicotinamide Mononucleotide) is C (limited — early or preliminary data, mostly mechanistic or animal). Promising mechanism. Animal data encouraging. Human clinical data limited.
Specific findings with supporting evidence:
- Precursor to NAD+. Evidence grade A.
- Animal studies show longevity benefits. Evidence grade B.
Best-supported outcomes:
- NAD+ support (theoretical).
- Research interest.
Where marketing outpaces evidence:
- The claim that "Proven to extend human lifespan" is not supported by the evidence (grade C).
- Marketing often overstates: Proven anti-aging.
- Marketing often overstates: Reverses human aging.
Dose and timing
The typical effective dose for NMN (Nicotinamide Mononucleotide) is 250–500 mg. Doses vary in studies; regulatory status uncertain.
Take it in the morning. Morning preferred.
Who it's for, and who should skip it
Most relevant for:
- Those following longevity research.
- People interested in NAD+ support.
Not appropriate for:
- Those expecting proven anti-aging.
- People wanting FDA-approved solutions.
Safety and cautions
Caution: FDA regulatory status. In 2022 the FDA took the position that NMN is excluded from the dietary-supplement definition because it had already been authorised for investigation as a new drug (Metro International Biotech citizen petition). NMN is still sold freely and is legal to buy, but it is not recognised by the FDA as a supplement. Amazon briefly delisted NMN listings over this. If you take NMN, assume the regulatory landscape can change. Limited human data. Most compelling data is from animal models.
Common mistakes
- Expecting proven longevity benefits.
- Ignoring regulatory concerns.
Myths vs reality
A common misconception: NMN reverses aging in humans. In reality, human longevity data is not established.
How it interacts with other compounds
- NMN (Nicotinamide Mononucleotide) works well alongside resveratrol — often discussed together for longevity.
Questions people ask
NMN vs NR? Both are NAD+ precursors. NR has more human data; NMN faces regulatory questions.
Editorial note
This guide summarizes the published evidence on NMN (Nicotinamide Mononucleotide). It is educational content, not medical advice. Confirm with your clinician if you take prescription medications or manage a chronic condition.